POME

Not Applicable

Recruiting

• Conditions: esophageal cancer

• Registration Number: JPRN-jRCT1040220010
• Lead Sponsor: Kei Muro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-23
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

1.Patients diagnosed with metastatic or recurrent esophageal squamous or adenosquamous cancer from January 1, 2013 to December 31, 2018
2. Age: 20 years or older
3. Patients in the above categories (1) to (4) of patients eligible for chemotherapy for esophageal cancer from January 2013 to the end of December 2018 who have received chemotherapy for metastasis or recurrence
4. Patients from whom appropriate consent is obtained (see General Informed Consent)

All inclusion and exclusion criteria will be reviewed by the investigator or qualified designee to ensure that the subject qualifies for the study.

Exclusion Criteria

Patients who were registered in a clinical study at the time of the first chemotherapy treatment for metastatic or recurrent esophageal cancer

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To investigate the patterns of treatment in patients who received a histological diagnosis of esophageal cancer (squamous, adenosquamous) who started chemotherapy for metastatic or recurrent esophageal cancer from January 1, 2013 to December 31, 2018.

Secondary Outcome Measures

Name	Time	Method
OS, clinical course (response rate, recurrence or metastasis, duration) and timings by type of chemotherapy, factors affecting outcomes